Alzheimers Res Ther Volume 5(1); 2013

|previous
|next
|latest
|archive

Volume 5(1); 2013

Research

Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application

Carina Wattmo, Erik Jedenius, Kaj Blennow, Åsa K Wallin

Alzheimers Res Ther. 2013; 5(1): 2. Published online 2013 January 3. doi: 10.1186/alzrt156

PMCID:: PMC3580330

Abstract Full Text PDF–341K

¹⁸F-florbetaben Aβ imaging in mild cognitive impairment

Kevin Ong, Victor L Villemagne, Alex Bahar-Fuchs, Fiona Lamb, Gaël Chételat, Parnesh Raniga, Rachel S Mulligan, Olivier Salvado, Barbara Putz, Katrin Roth, Colin L Masters, Cornelia B Reininger, Christopher C Rowe

Alzheimers Res Ther. 2013; 5(1): 4. Published online 2013 January 16. doi: 10.1186/alzrt158

PMCID:: PMC3580329

Abstract Full Text PDF–1019K Supplementary Material

Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy

Alireza Atri, José L Molinuevo, Ole Lemming, Yvonne Wirth, Irena Pulte, David Wilkinson

Alzheimers Res Ther. 2013; 5(1): 6. Published online 2013 January 21. doi: 10.1186/alzrt160

PMCID:: PMC3580327

Abstract Full Text PDF–521K

Articles from Alzheimer's Research & Therapy are provided here courtesy of
BioMed Central

PMC Canada | Copyright | Disclaimer

PubMed Central Canada is a service of the Canadian Institutes of Health Research (CIHR) working in partnership with the National Research Council's Canada Institute for Scientific and Technical Information in cooperation with the National Center for Biotechnology Information at the U.S. National Library of Medicine(NCBI/NLM). It includes content provided to the PubMed Central International archive by participating publishers.